Guidance for completing the Drug Submission Application Form

For Drug Identification Number applications, a separate completed HC/SC 3011 must be provided for each formulation, strength and dosage form. For all other submission types, only a separate completed Part 2 must be provided for each formulation, strength and dosage form.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-09-01

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data